The 14th edition of South Asia’s biggest pharma event CPhI & P-Mec India expo opened yesterday at the India Expo Centre, Greater Noida, Delhi-NCR. The three-day expo is set to witness over 534 exhibitors from 16 countries and over 20,000 visitors.
The expo was inaugurated by Guests of Honour Ravi Uday Bhaskar, Director General, Pharmexcil; Bodh Raj Sikri, Co-Chairperson, Federation of Pharma Entrepreneurs; Dr Viranchi Shah, Senior Vice President and National President (Elect), Indian Drug Manufacturers Association; AVPS Chakravarthy, Ambassador, World Packaging Organization and Board Member of Pharmexcil; Yogesh Mudras, Managing Director, Informa Markets, India and Rahul Deshpande, Group Director, Informa Markets, India, amidst an august industry presence.
With a focus on building new business partnerships and announcements, the three-day expo intends to deliver and discuss new trends in the industry to grow the economy. The event is hosting a line-up of conferences by addressing the challenges and focussing on future opportunities of the pharmaceutical industry in India while adapting and thriving in this ever-changing industry.
The expo is supported by participants from various pharmaceutical companies (generic finished products), API producers, distributors, pharmaceutical companies (innovator finished products), intermediates manufacturers, engineering and contract manufacturers, ingredients distributors/buyers, consultancies and packaging materials companies. The expo is well received by the industry and associations such as – Pharmexcil, CIPI, IDMA, ASPA, IPA, IPEC and KDPMA.
The expo, which is a part of the India Pharma Week, culminated with sessions on Day 1 under The Pharma Connect Conference that addressed ‘Policy Trigger and National Commitment to Nurturing Resilient Pharma Value Chain,’ ‘Leverage Digitalisation to Enhance Existing Pharmaceutical Manufacturing Plants,’ ‘Understanding the Criticality of Catalyst Development through Case Studies’ and ‘Global Pharma Opportunity and Expanding Indian Footprint.’
The CEO Roundtable, which was a closed-door strategic gathering of CEOs of leading pharma and biopharma companies, deep-dived into thought-provoking discussions on pharma developments in India which was chaired by KG Ananthakrishnan, Director-General, OPPI and co-chaired by Sriram Shrinivasan, Consulting CHS Leader, EY India. The roundtable witnessed the presence of leaders such as Anandram Narasimhan, Managing Director, Merck Specialities; Suresh Patatthil, General Manager, Abbvie India; BR Sikri, Co-Chairman, Federation of Pharma Entrepreneurs (FOPE); Dr Viranchi Shah, Director, Saga Laboratories; Franck Toussaint, Executive Director and Co-founder, BSMA Europe; Sanjit Singh Lamba, CEO, Valence to name a few.
Speaking at the inauguration of the 14th edition of CPhI & P-Mec India Expo, Yogesh Mudras, Managing Director, Informa Markets, India, said, “The past 13 editions of the CPhI & P-Mec India expo have paved the way for advancement in the pharma space. It is always a pleasure for us to provide a forum to the industry leaders to present their contributions to the industry, and at the same time, witness those of their peers. The overwhelming response from the exhibitors and the discussions at the conference will provide great insight into the industry. The aim is to capture new market trends, innovate, adapt and seek newer opportunities, in this dynamic global market. On this note, we look forward to a great show, and we wish all our guests a safe and productive experience at the India Pharma Week.”
The India Pharma Awards (IPA) and Networking Night: A part of the Recognition and Networking stream of the IPW, the 8th edition of the India Pharma Awards will bring together industry champions, stalwarts, visionaries and organisations from the pharma universe. The India Pharma Awards is one of the most transparent and process-driven awards. It is conducted professionally as well as methodically to draw out the best in the industry. This is done with a neutral jury panel representing various segments of the industry in a two-round process of sifting through the nominations. This year, the IPA received 159 nominations with categories such as excellence in R&D, excellence in brand/product management, excellence in marketing communications, excellence in CSR and excellence in response to COVID-19, among many others.